Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
361 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//POLYOMAVIRUS | 35836 |
818 | 2 | ONCOLYTIC VIRUS//GENE THERAPY//HUMAN GENE THERAPY | 12130 |
957 | 1 | ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS | 2970 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | authKW | 2710946 | 12% | 71% | 361 |
2 | VIROTHERAPY | authKW | 1146417 | 6% | 65% | 166 |
3 | ONCOLYTIC ADENOVIRUS | authKW | 1009584 | 5% | 59% | 160 |
4 | ONCOLYTIC | authKW | 688590 | 3% | 66% | 99 |
5 | ONCOLYTIC VIROTHERAPY | authKW | 627086 | 3% | 73% | 81 |
6 | CANC GENE THER Y GRP | address | 563132 | 3% | 58% | 91 |
7 | ONCOLYSIS | authKW | 496524 | 2% | 63% | 74 |
8 | SAN DIEGO SCI | address | 319535 | 2% | 60% | 50 |
9 | CANCER GENE THERAPY | journal | 253080 | 7% | 11% | 216 |
10 | G207 | authKW | 223267 | 1% | 96% | 22 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 27577 | 36% | 0% | 1080 |
2 | Oncology | 20155 | 43% | 0% | 1280 |
3 | Biotechnology & Applied Microbiology | 16389 | 32% | 0% | 948 |
4 | Genetics & Heredity | 14174 | 29% | 0% | 867 |
5 | Virology | 4935 | 10% | 0% | 302 |
6 | Cell Biology | 259 | 7% | 0% | 204 |
7 | Biochemistry & Molecular Biology | 236 | 12% | 0% | 358 |
8 | Multidisciplinary Sciences | 59 | 1% | 0% | 31 |
9 | Mathematical & Computational Biology | 41 | 1% | 0% | 30 |
10 | Gastroenterology & Hepatology | 16 | 2% | 0% | 45 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC GENE THER Y GRP | 563132 | 3% | 58% | 91 |
2 | SAN DIEGO SCI | 319535 | 2% | 60% | 50 |
3 | HUMAN GENE THER Y | 150345 | 3% | 14% | 98 |
4 | REBECCA JOHN MOO COMPREHENS CANC | 137243 | 1% | 45% | 29 |
5 | XINYUAN MED BIOTECHNOL | 129047 | 1% | 31% | 39 |
6 | FINNISH MOL MED | 123975 | 1% | 39% | 30 |
7 | MOL NEUROSURG | 123070 | 1% | 28% | 42 |
8 | DARDINGER NEUROONCOL NEUROSCI | 118962 | 1% | 42% | 27 |
9 | IMMUNOVIROTHER Y | 115524 | 0% | 78% | 14 |
10 | GENE CELL THER Y | 87556 | 1% | 24% | 34 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 253080 | 7% | 11% | 216 |
2 | MOLECULAR THERAPY-ONCOLYTICS | 185638 | 1% | 50% | 35 |
3 | MOLECULAR THERAPY | 161940 | 8% | 6% | 237 |
4 | GENE THERAPY | 74554 | 6% | 4% | 167 |
5 | HUMAN GENE THERAPY | 38530 | 4% | 3% | 111 |
6 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 14821 | 1% | 4% | 35 |
7 | CLINICAL CANCER RESEARCH | 13244 | 5% | 1% | 139 |
8 | JOURNAL OF GENE MEDICINE | 12341 | 1% | 3% | 41 |
9 | HUMAN GENE THERAPY CLINICAL DEVELOPMENT | 11641 | 0% | 11% | 10 |
10 | CANCER RESEARCH | 9522 | 6% | 0% | 190 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | 2710946 | 12% | 71% | 361 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
2 | VIROTHERAPY | 1146417 | 6% | 65% | 166 | Search VIROTHERAPY | Search VIROTHERAPY |
3 | ONCOLYTIC ADENOVIRUS | 1009584 | 5% | 59% | 160 | Search ONCOLYTIC+ADENOVIRUS | Search ONCOLYTIC+ADENOVIRUS |
4 | ONCOLYTIC | 688590 | 3% | 66% | 99 | Search ONCOLYTIC | Search ONCOLYTIC |
5 | ONCOLYTIC VIROTHERAPY | 627086 | 3% | 73% | 81 | Search ONCOLYTIC+VIROTHERAPY | Search ONCOLYTIC+VIROTHERAPY |
6 | ONCOLYSIS | 496524 | 2% | 63% | 74 | Search ONCOLYSIS | Search ONCOLYSIS |
7 | G207 | 223267 | 1% | 96% | 22 | Search G207 | Search G207 |
8 | ONCOLYTIC VIRAL THERAPY | 187152 | 1% | 84% | 21 | Search ONCOLYTIC+VIRAL+THERAPY | Search ONCOLYTIC+VIRAL+THERAPY |
9 | REOVIRUS | 185503 | 3% | 22% | 81 | Search REOVIRUS | Search REOVIRUS |
10 | CONDITIONALLY REPLICATIVE ADENOVIRUS | 176825 | 1% | 83% | 20 | Search CONDITIONALLY+REPLICATIVE+ADENOVIRUS | Search CONDITIONALLY+REPLICATIVE+ADENOVIRUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |